Lymphoma Industry, April 2015 Market Reports from Top Publishers

You might be interested in: Diagnostics, in Vitro Diagnostic Reagent, Drug, Clinical Trial, Flow Cytometry, Antibody, Nuclear Imaging Equipment, Biomarker, Cancer Diagnostic, Cloud Computing, Oncology, Pharmaceutical.


 
1-10 of about 100 reports for Lymphoma

Purchase Reports From Reputable Market Research Publishers

Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014

Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Acute Lymphoblastic ...

Non-Hodgkin Lymphoma Partnering 2010-2015

Non-Hodgkin Lymphoma Partnering 2010-2015

  • $ 795
  • Industry report
  • March 2015
  • by Currentpartnering

The Non-Hodgkin Lymphoma Partnering 2010-2015 report provides understanding and access to the non-hodgkin lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. ...

Lymphoma Partnering 2010-2015

Lymphoma Partnering 2010-2015

  • $ 995
  • Industry report
  • March 2015
  • by Currentpartnering

The Lymphoma Partnering 2010-2015 report provides understanding and access to the lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in lymphoma partnering ...

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Global Markets Direct

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015’, provides an overview of the Peripheral ...

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Global Markets Direct

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s ...

Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015

Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Global Markets Direct

Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Acute Lymphoblastic ...

T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs ...

Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

About 3 600 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2015
    33 pages
  • Cancer  

    Lymphoma  

    Chemotherapy  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.